Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

High Prevalence of Nickel Allergy in an Overweight Female Population: A Microbial Metallomics Commentary Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More
  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

November 27, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Microbial Metallomics
    Microbial Metallomics

    Microbial Metallomics is the study of how microorganisms acquire, use, regulate, and transform metals in any biological or environmental context.

  • Low‑Nickel Diet (LNiD)
    Low‑Nickel Diet (LNiD)

    A low-nickel diet (LNiD) is a therapeutic dietary intervention that eliminates high-nickel foods, primarily plant-based sources such as legumes, nuts, whole grains, and cocoa, to reduce systemic nickel exposure. It is clinically validated for managing systemic nickel allergy syndrome (SNAS) and nickel-induced eczema. Its relevance is well-established in microbiome modulation, with studies demonstrating clinical benefits in conditions such as endometriosis, fibromyalgia, irritable bowel syndrome, and GERD.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More
  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2025-06-09

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was studied?

This pilot observational analysis examined the high prevalence of nickel allergy in overweight adults and the potential impact of a low-nickel diet on body mass index (BMI) and waist circumference. The focus keyphrase nickel allergy in overweight females appears directly in this section, as the study centers on metabolic and inflammatory profiles in individuals with elevated BMI who exhibit delayed hypersensitivity to nickel. Drawing from patch-test results, metabolic data, and dietary intervention outcomes, the investigators evaluated whether nickel-sensitive overweight subjects—especially women—display a distinctive clinical pattern. The study connects systemic nickel exposure not only to dermatologic and gastrointestinal symptoms but also to metabolic derangements and potential microbiome-related mechanisms, including the role of nickel-dependent bacteria such as Helicobacter pylori (page 6), which may promote inflammation and alter gut energy extraction.

Who was studied?

Eighty-seven overweight adults (BMI >26 kg/m²) were consecutively enrolled at an Italian Red Cross preventive health program. The population was predominantly female (72 of 87; 82.8%), enabling more detailed analysis in women. Laboratory, anthropometric, and metabolic assessments were collected for all participants, including liver enzymes, glucose, insulin, lipid profile, and HOMA-IR (page 4). Patch testing for nickel sulfate identified 45 nickel-allergic individuals, with the overwhelming majority being women (43 of 45). Among nickel-allergic participants, 43 women and 2 men initiated a low-nickel diet. Twenty-four women completed the 24-week follow-up, permitting analysis of longitudinal anthropometric outcomes.

Most important findings

In this cohort, nickel allergy appeared substantially more common in overweight women than in the general population, and higher still when metabolic syndrome and hepatic steatosis were present. Individuals adhering to a low-nickel diet demonstrated clinically relevant reductions in BMI, waist circumference, and body fat. Mechanistically, the study highlights intersecting inflammatory and microbiome pathways: IL-17–driven immune activity, menopausal immune shifts, and nickel-dependent bacteria such as H. pylori, which may collectively intensify metabolic dysfunction. The findings suggest that excess dietary nickel may amplify systemic inflammation and alter gut microbial composition, thereby contributing to obesity-associated phenotypes.

DomainCondensed Insight
Nickel allergy prevalenceOverweight women showed a 59.7% nickel allergy rate versus 12.5% in the general female population. Prevalence increased to 61.1% in those with metabolic syndrome and liver steatosis.
Anthropometric response to low-nickel dietAfter 24 weeks, nickel-allergic overweight women experienced a mean BMI reduction of 4.2 ± 0.5 kg/m² and a waist decrease of 11.7 ± 0.6 cm, with parallel declines in body fat percentage.
Inflammatory mechanismsObesity and nickel allergy both upregulate IL-17; menopausal estrogen decline further enhances Th17 activity, potentially intensifying systemic inflammation in nickel-sensitive women.
Microbiome-related effectsNickel supports growth of specific bacteria, including H. pylori. High dietary nickel may favor nickel-dependent gut microbes, promoting inflammation and metabolic imbalance; low-nickel diets may aid eradication.

Key implications

This study suggests that nickel allergy may be substantially more common in overweight females than in the general population, and that reducing dietary nickel could meaningfully improve anthropometric outcomes in nickel-sensitive individuals. The combination of inflammatory pathways, estrogen-related shifts in IL-17 biology, and nickel-dependent microbial ecology positions nickel exposure as a possible modifiable factor in obesity and metabolic dysfunction. Although preliminary and limited by sample size and lack of control group, these findings imply that clinicians addressing unexplained weight gain, metabolic syndrome, gastrointestinal symptoms, or systemic inflammation—especially in perimenopausal women—may consider evaluating nickel sensitivity and dietary nickel intake.

Citation

Lusi EA, Di Ciommo VM, Patrissi T, Guarascio P. High prevalence of nickel allergy in an overweight female population: a pilot observational analysis.PLoS One. 2015;10(3):e0123265. file (4)

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.